The latest Business updates from the science industry
by Heather Hobbs Finnish cornerstone builds on hub creation Health economics and outcomes research (HEOR) consulting
organisation Quantify Research has marked an important strategic milestone with the opening of its new office in Helsinki. Founded in 2011 the Stockholm-based company specialises in the development of real-world evidence, data science, health economics, market access & modelling and evidence and has a broad collaborative network with stakeholders including academic institutions, governmental authorities and patient groups. Primarily covering Europe and North America, the company also has locations in Oslo, Copenhagen and Chandigarh, India.
“As we open our doors in Finland, we’re not just expanding geographically, but enriching the ways we serve and engage with our clients,” said Kirk Geale, CEO of Quantify Research. “Although Finnish market access and
real-world evidence services have long been part of Quantify’s offering, this new location will enable us to provide stronger, more personalised services to our Finnish clients. Our global clients will benefi t from increasingly powerful RWE solutions using Finland’s cutting-edge genetic and EHR data. Dear Finland – Nyt mennään (Now lets go)!
With a mission to enable evidence-based medicine and support healthcare decision-making to give patients access to essential medical treatments worldwide, the new Finnish offi ce will be fully integrated with its other locations, creating a cross-Nordic strategic access and evidence hub.
More information online:
ilmt.co/PL/KYnj 62200pr@reply-direct.com
Kirk Geale
Data platform offers potential for structure-based drug design
allows scientists to determine 3D protein structures experimentally and visualise relevant targets in their native or drug-bound state.
The Utrecht-based company’s platform can better support scientists by addressing high costs, complexity and other compute infrastructure ineffi ciencies, through its user-friendly web app offering scalable cloud storage and powerful data analysis workfl ows.
Marta-Gaia Zanchi, Founder & Managing Partner at Nina Capital remarked: “CryoCloud’s innovative approach to leveraging cloud technology in cryo-EM is not just a major step for structural biology, but a testament to the transformative power of digital solutions in the life sciences sector.”
Pictured from left: Robert Englmeier and Boy Persoon (CPO)
Dutch biotech CryoCloud, a start-up that has rapidly progressed from concept through accelerator programs, is now advancing development of its cloud-native cryo-EM data analysis platform having closed a €500,000 pre-seed funding round. Co-founded in 2021 by Robert Englmeier, Ilja Gubins and Boy Persoon, the company’s platform is designed to enhance the accessibility and effi ciency of cryo-EM in drug development and research.
The fi nancing round was led by Nina Capital, with signifi cant contributions from Utrecht Health Seed Fund and ROM Utrecht Region, underscoring the confi dence in CryoCloud’s potential to disrupt the traditional cryo-EM landscape. Unlike predictive tools, the Nobel Prize-winning technique of Cryo-electron microscopy
The funding will be instrumental in the platforms further development, advancing data analysis features and integrating AI to optimise cryoEM data processing. This aligns with the broader industry trend towards digitalisation and automation in the life sciences, which promises to enhance research effi ciency and reduce turnaround times for critical projects.
On the company’s progress, Irene van de Poll, Investment Manager at ROM Utrecht, noted: “The team at CryoCloud have managed to build out their cloud-based platform in a short time and are already creating traction. Their technology can have an enormous impact on the speed of development in the life sciences sector.”
Refl ecting on the importance of innovation in the fi eld, Robert Englmeier, CEO of CryoCloud, stated: “The landscape and throughput of cryo-EM has evolved signifi cantly in the last 6 years, yet the way data is analysed remained the same - leading to bottlenecks and creating entrance barriers. Our mission is to make cryo-EM more accessible and to streamline the research process, which is now possible with our platform.”
Pictured from left: Robert Englmeier and Ilja Gubins (CTO)
“We are happy to invest in CryoCloud’s solutions, to make the complex and costly process of CryoEM analysis more accessible to researchers” said Timo Koopmans, Investment Manager at the Utrecht Health Seed Fund. “Their platform has the potential to greatly expand the use of CryoEM in the life sciences.”
Preparing for its next phase of growth, the company is poised to attract further investment and forge partnerships with leading companies and key opinion leaders in the fi eld.
More information online:
ilmt.co/PL/V2vd 62258pr@reply-direct.com
3D printed samples to face lunar compatibility tests
Polymer 3D printing solutions provider Stratasys is joining an upcoming lunar mission that will test the performance of 3D-printed materials on the surface of the moon. The experiments are part of Aegis Aerospace Inc’s fi rst Space Science & Technology Evaluation Facility mission (SSTEF-1), a commercial space testing service developed under NASA’s Tipping Point program, to provide R&D services on the lunar surface. The Stratasys experiments are sponsored by Northrop Grumman Corporation.
In this moon mission, 3D-printed samples will be brought to the lunar surface by an unmanned lander in a carrier structure 3D-printed by Stratasys. Three materials will be the focus of two different experiments led by Northrop Grumman.
The fi rst experiment assesses the performance of a sample coupon
part made with Stratasys’ Antero® 800NA FDM® fi lament fi lled with tungsten. This is a high-performance PEKK-based thermoplastic with demonstrating good mechanical properties, chemical resistance and low outgassing characteristics. Adding tungsten is intended to provide shielding against harmful radiation such as gamma rays or x-rays.
The second passive experiment is designed to see how 3D-printed materials perform in space. It will include Antero 840CN03 FDM fi lament, which features electrostatic discharge (ESD) properties for use with electronics and was used on the Orion spacecraft. The experiment will also include a new ESD photopolymer manufactured by Stratasys partner Henkel for use with Stratasys’ Origin® One 3D printers and designed for high-heat environments. This experiment will subject coupon samples of the 3D-printed
materials to moon dust, low pressure that can lead to outgassing and the rapid temperature swings that result from virtually no atmosphere on the moon.
“Additive manufacturing is an important technology for space missions
where every ounce of weight matters and high
performance is essential,” said Chief Industrial Business Offi cer Rich Garrity. “This set of experiments will help us understand how to fully leverage 3D printing to keep people and equipment safe as we travel to the moon and beyond.”
More information online:
ilmt.co/PL/lvBZ 62285pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
